{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:42:40Z","timestamp":1776472960798,"version":"3.51.2"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2006.10.058","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T12:20:09Z","timestamp":1169122809000},"page":"104-112","source":"Crossref","is-referenced-by-count":12,"title":["Is lipid lowering treatment aiming for very low LDL levels safe in terms of the synthesis of steroid hormones?"],"prefix":"10.1016","volume":"69","author":[{"given":"Mustafa","family":"Kanat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Sipahioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Arinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdinc","family":"Serin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozcan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydin","family":"Tunckale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harika","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2006.10.058_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib2","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":"A definition of initial, fatty streak, and intermediate lessions of atherosclerosis: a report from the committee on vascular lessions of the council on arteriosclerosis, American Heart Association","volume":"89","author":"Stary","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2006.10.058_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/10641968909035380","article-title":"Biology of cholesterol, lipoproteins and atherosclerosis","volume":"11","author":"Havel","year":"1989","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.mehy.2006.10.058_bib5","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III ) final report. Circulation 2002;106:3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.mehy.2006.10.058_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2006.10.058_bib7","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.1986.03380200061022","article-title":"Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)","volume":"256","author":"Stamler","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2006.10.058_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The lipid research clinics coronary primary prevention trial results. I: Reduction in the incidence of coronary heart disease","volume":"251","author":"Lipid Research Clinics Program","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2006.10.058_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1984.03340270043026","article-title":"The lipid research clinics coronary primary prevention trial results. II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering","volume":"251","author":"Lipid Research Clinics Program","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2006.10.058_bib10","doi-asserted-by":"crossref","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383\u20139.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"issue":"9326","key":"10.1016\/j.mehy.2006.10.058_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Provastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Pravastatin or Atorvastatin Evaluation and Infection Therapy \u2013 Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndomes","volume":"350","author":"Cannon","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib15","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib16","first-page":"843","article-title":"HMG CoA reductase inhibitors: a look back and a look ahead","volume":"8","author":"Davignon","year":"1992","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0195-668X(02)00807-2","article-title":"Effects of ezetimibe, a new cholesterol absorbtion inhibitor, on plasma lipids in patients with primary hypercholesterolemia","volume":"24","author":"Knopp","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2006.10.058_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implication of recent clinical trials for the national cholesterol education program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2006.10.058_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.mehy.2006.10.058_bib20","first-page":"941","article-title":"Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia","volume":"88","author":"Glueck","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archinte.1991.00400050113021","article-title":"Serum cholesterol and mortality among Japanese\u2013American men: the Honolulu (Hawaii) Heart Program","volume":"151","author":"Stemmermann","year":"1991","journal-title":"Arch Int Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib22","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archinte.1992.00400190110021","article-title":"Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial","volume":"152","author":"Neaton","year":"1992","journal-title":"Arch Int Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0895-4356(94)90110-4","article-title":"Serum total cholesterol and mortality in a Japanese population","volume":"47","author":"Iso","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ecl.2005.01.002","article-title":"Adrenal corticosteroid biosynthesis, metabolism, and action","volume":"34","author":"Arlt","year":"2005","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.mehy.2006.10.058_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/edrv-3-3-299","article-title":"The role of lipoprotein in steroidogenesis and cholesterol metabolism in steroidogenic glands","volume":"3","author":"Gwynne","year":"1982","journal-title":"Endocr Rev"},{"key":"10.1016\/j.mehy.2006.10.058_bib26","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/S0021-9258(17)40133-5","article-title":"Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured moused adrenal cells","volume":"252","author":"Faust","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2006.10.058_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/279679a0","article-title":"Coated pits, coated vesicles, and receptor-mediated endocytosis","volume":"279","author":"Goldstein","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2006.10.058_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI105580","article-title":"Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation","volume":"46","author":"Borkowski","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2006.10.058_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-54-1-27","article-title":"Adrenal function in heterozygous and homozygous hypobetalipoproteinemia","volume":"54","author":"Illingworth","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2006.10.058_bib30","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0026-0495(83)90075-6","article-title":"Adrenal cortical function in homozygous familial hypercholesterolemia","volume":"32","author":"Illingworth","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2006.10.058_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"27","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.mehy.2006.10.058_bib32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI118883","article-title":"Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat","volume":"98","author":"Landschulz","year":"1996","journal-title":"J Clin Invest"},{"issue":"Suppl. 4","key":"10.1016\/j.mehy.2006.10.058_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androjen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mehy.2006.10.058_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0002-9378(83)90743-3","article-title":"Regulation of human fetal testicular secretion of testosterone: low-density-lipoprotein\u2013cholesterol and cholesterol synthesized de novo as steroid precursor","volume":"146","author":"Carr","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2006.10.058_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0015-0282(16)46511-8","article-title":"The role of lipoproteins in the regulation of progesterone secretion by the human corpus luteum","volume":"38","author":"Carr","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mehy.2006.10.058_bib36","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1210\/jc.83.3.983","article-title":"Human granulosa cells use high density lipoprotein cholesterol for steroidogenesis","volume":"83","author":"Azhar","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mehy.2006.10.058_bib37","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2165\/00003495-200161120-00012","article-title":"Atorvastatin. An update review of its pharmacological properties and use in dyslipidaemia","volume":"61","author":"Malhotra","year":"2001","journal-title":"Drugs"},{"issue":"March 1","key":"10.1016\/j.mehy.2006.10.058_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) [published erratum appears in Am J Cardiol 1998 Jul 1;82(1):128] [see comments]","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.mehy.2006.10.058_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9149(00)00942-5","article-title":"Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoproteinA-I levels","volume":"86","author":"Kastelein","year":"2000","journal-title":"Am J Cardiol"},{"issue":"May 15","key":"10.1016\/j.mehy.2006.10.058_bib40","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0002-9149(99)00153-8","article-title":"Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I","volume":"83","author":"Crouse","year":"1999","journal-title":"Am J Cardiol"},{"issue":"144 Suppl. 1","key":"10.1016\/j.mehy.2006.10.058_bib41","first-page":"25","article-title":"Effect of statin therapy on HDL\u2013C levels in patients with type IIa and type IIb hyperlipidemia [abstract]","volume":"28","author":"Nawrocki","year":"1999","journal-title":"Atherosclerosis"},{"issue":"May","key":"10.1016\/j.mehy.2006.10.058_bib42","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0033-0620(60)80030-8","article-title":"The effect of MER-29, a cholesterol synthesis inhibitor, on adrenal function, blood clotting mechanisms, and serum lipids, before and after simulated stress in man","volume":"2","author":"Ford","year":"1960","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.mehy.2006.10.058_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/jcem-50-5-977","article-title":"Impaired cortisol secretion in abetalipoproteinemia","volume":"50","author":"Illingworth","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.058_bib44","first-page":"115","article-title":"Corticosteroid production in abetalipoproteinemia: evidence for an impaired response ACTH","volume":"100","author":"Illingworth","year":"1982","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.058_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-54-1-27","article-title":"Adrenal function in heterozygous and homozygous hypobetalipoproteinemia","volume":"54","author":"Illingworth","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mehy.2006.10.058_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0026-0495(83)90075-6","article-title":"Adrenal cortical function in homozygous familial hypercholesterolemia","volume":"32","author":"Illingworth","year":"1983","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.mehy.2006.10.058_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1210\/jcem-58-1-206","article-title":"Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia","volume":"58","author":"Illingworth","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2006.10.058_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-2275(20)40127-0","article-title":"Aberrant hypothalamic-pituitary-ovarian axis in the Watanabe heritable hyperlipidemic rabbit","volume":"35","author":"Robins","year":"1994","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.mehy.2006.10.058_bib49","first-page":"556","article-title":"The genetic relationship of abetalipoproteinemia and hypobetalipoproteinemia: a report of the occurence of both diseases within the same family","volume":"85","author":"Biemer","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.mehy.2006.10.058_bib50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jc.80.3.836","article-title":"Sustained Therapy with 3-Hydroxy-3-Methylglutaryl-Coenzyme-A Reductase Inhibitors Does Not Impair Steroidogenesis by Adrenals and Gonads","volume":"80","author":"Travia","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2006.10.058_bib51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-54-2-367","article-title":"Progesterone synthesis by luteinized human granulosa cells in culture: the role of de novo sterol synthesis and lipoprotein-carried sterol","volume":"54","author":"Tureck","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2006.10.058_bib52","doi-asserted-by":"crossref","first-page":"16J","DOI":"10.1016\/0002-9149(88)90003-3","article-title":"Preclinical evaluation of lovastatin","volume":"62","author":"MacDonald","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0140-6736(90)90245-Z","article-title":"Adrenocortical function in patients on simvastatin","volume":"335","author":"Mol","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-2007-1002161","article-title":"Simvastatin influences testicular steroidogenesis in human","volume":"25","author":"Rossato","year":"1993","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.mehy.2006.10.058_bib55","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/0026-0495(93)90272-P","article-title":"Long-term endocrine function in hypercholesterolemic patient treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"42","author":"Dobs","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2006.10.058_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2007-979159","article-title":"Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment","volume":"28","author":"Azzarito","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.mehy.2006.10.058_bib57","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1210\/jcem-65-3-546","article-title":"Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin","volume":"65","author":"Farnsworth","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2006.10.058_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0002-9149(98)00421-4","article-title":"Efficacy and safety of simvastatin 80mg\/day in hypercholesterolemic patients","volume":"82","author":"Stein","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib59","first-page":"143","article-title":"Efficacy and six-month safety of simvastatin 80mg\/day: results from the Worldwide Simvastatin Expanded Dose Program (WSEDP)","volume":"8","author":"Ose","year":"1998","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.mehy.2006.10.058_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(96)00742-4","article-title":"The efficacy and six-week tolerability of simvastatin 80 and 160mg\/day","volume":"79","author":"Davidson","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib61","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2000.7716a","article-title":"Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia","volume":"49","author":"Dobs","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2006.10.058_bib62","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia","volume":"106","author":"De Jongh","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2006.10.058_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00314921","article-title":"Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia","volume":"42","author":"Purvis","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2006.10.058_bib64","first-page":"410","article-title":"Effect of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones","volume":"12","author":"Ide","year":"1990","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.mehy.2006.10.058_bib65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5551\/jat.10.160","article-title":"Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia","volume":"10","author":"Santini","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.mehy.2006.10.058_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00392-004-1003-2","article-title":"Does statin therapy influence steroid hormone synthesis?","volume":"93","author":"B\u00f6hm","year":"2004","journal-title":"Z Kardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib67","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0026-0495(00)90938-7","article-title":"Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients","volume":"49","author":"Dobs","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2006.10.058_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0140-6736(90)90182-5","article-title":"Cortisol secretion in patients on simvastatin","volume":"335","author":"Candrina","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2006.10.058_bib69","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2125.1991.tb03924.x","article-title":"Effect of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia","volume":"32","author":"Jay","year":"1991","journal-title":"Br J Clin Pharm"},{"key":"10.1016\/j.mehy.2006.10.058_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0006-291X(89)92773-3","article-title":"Tissue selectivity of the cholesterol lowering agents lovastatin, simvastatin and pravastatin in rats in vivo","volume":"158","author":"Germershausen","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2006.10.058_bib71","doi-asserted-by":"crossref","first-page":"3D","DOI":"10.1016\/0002-9149(94)90626-2","article-title":"Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"73","author":"Blum","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2006.10.058_bib72","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2006.10.058_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.mehy.2006.10.058_bib74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/clinchem\/41.2.232","article-title":"Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated","volume":"41","author":"McNamara","year":"1995","journal-title":"Clin Chem"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770600853X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770600853X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T20:58:31Z","timestamp":1628369911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698770600853X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S030698770600853X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2006.10.058","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}